For example, diseases like secondary lymphedema and obesity largely show decreased VEGFR3 signaling despite increased VEGF-C ligand expression in affected tissues, indicating a probable development of VEGF-C resistance in these pathologies, akin to the phenomenon of insulin resistance [201]. This evidence concerns the gene VEGFC and obesity disorder.